Locations
Boston, MA, USA · West Street / River Street, Boston, MA, USA
industry
Biotechnology · Data and Analytics · DeepTech · Health · Software
Size
51-200 employees
Stage
Series B
founded in
2017
Asimov is a synthetic biology company that provides an integrated suite of cells, genes, and software to enable advanced genetic design and manufacture of therapies. Their platform includes engineered host cells, a genetic parts library, and cloud-based design software, allowing clients to develop custom cell lines and optimize genetic constructs. Asimov differentiates itself through its comprehensive approach, combining synthetic biology with computational tools, and has achieved significant traction with partnerships across the biotech industry, including over 25 companies from small biotechs to large pharmaceutical firms. The company is positioned at the forefront of the synthetic biology market, leveraging AI and machine learning to enhance genetic engineering capabilities.
Something looks off?On-site & Remote